{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:57:27Z","timestamp":1790092647629,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370599"],"award-info":[{"award-number":["82370599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.metabol.2025.156175","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:10:08Z","timestamp":1741133408000},"page":"156175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Arrestin domain containing 3 promotes alcohol-induced liver steatosis by reducing stearoyl-CoA desaturase-1 ubiquitinated degradation"],"prefix":"10.1016","volume":"167","author":[{"given":"Ying","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156175_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2025.156175_bb0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.metabol.2025.156175_bb0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2025.156175_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156175_bb0025","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41575-024-00936-x","article-title":"Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel consensus statement","volume":"21","author":"Lee","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2025.156175_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","article-title":"Effect of ethanol on lipid metabolism","volume":"70","author":"You","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2025.156175_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155740","article-title":"Gut-derived ammonia contributes to alcohol-related fatty liver development via facilitating ethanol metabolism and provoking ATF4-dependent de novo lipogenesis activation","volume":"151","author":"Song","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156175_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155656","article-title":"Alcoholic Setdb1 suppression promotes hepatosteatosis in mice by strengthening Plin2","volume":"146","author":"Zhang","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156175_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107752","article-title":"Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways","volume":"222","author":"Wen","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.metabol.2025.156175_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plipres.2012.08.002","article-title":"Stearoyl-CoA desaturase: rogue or innocent bystander?","volume":"52","author":"Hodson","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2025.156175_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-021-02067-6","article-title":"SCD1, autophagy and cancer: implications for therapy","volume":"40","author":"Ascenzi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.metabol.2025.156175_bb0060","volume":"3","author":"Parlati","year":"2021","journal-title":"New targets for NAFLD JHEP Rep"},{"key":"10.1016\/j.metabol.2025.156175_bb0065","doi-asserted-by":"crossref","unstructured":"AM AL, Syed DN, Ntambi JM. Insights into Stearoyl-CoA Desaturase-1 regulation of systemic metabolism. Trends Endocrinol Metab 2017;28:831\u201342.","DOI":"10.1016\/j.tem.2017.10.003"},{"key":"10.1016\/j.metabol.2025.156175_bb0070","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112304","article-title":"p53 protects against alcoholic fatty liver disease via ALDH2 inhibition","volume":"42","author":"Yao","year":"2023","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2025.156175_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13024-024-00778-w","article-title":"Stearoyl-CoA desaturase-1: a potential therapeutic target for neurological disorders","volume":"19","author":"Loix","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.metabol.2025.156175_bb0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.trecan.2023.03.003","article-title":"Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis","volume":"9","author":"Sen","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.metabol.2025.156175_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142500","article-title":"Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy","volume":"131","author":"Raas","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156175_bb0090","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1089\/ars.2021.0193","article-title":"The \u03b1-Arrestin ARRDC3 is an emerging multifunctional adaptor protein in Cancer","volume":"36","author":"Wedegaertner","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2025.156175_bb0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cmet.2011.08.011","article-title":"The arrestin domain-containing 3 protein regulates body mass and energy expenditure","volume":"14","author":"Patwari","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2025.156175_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/ars.2021.0038","article-title":"Thioredoxin-interacting protein in Cancer and diabetes","volume":"36","author":"Masutani","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2025.156175_bb0105","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.254888","article-title":"\u03b1-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis","volume":"134","author":"Arakaki","year":"2021","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2025.156175_bb0110","first-page":"10","article-title":"The role of Arrestin domain-containing 3 in regulating endocytic recycling and extracellular vesicle sorting of integrin \u03b24 in breast Cancer","author":"Soung","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.metabol.2025.156175_bb0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41418-023-01249-3","article-title":"Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses","volume":"31","author":"La Marca","year":"2024","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.metabol.2025.156175_bb0120","first-page":"5","article-title":"Arrestin domain containing 3 promotes Helicobacter pylori-associated gastritis by regulating protease-activated receptor 1","author":"Liu","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2025.156175_bb0125","article-title":"Hepatitis B virus X protein induces ALDH2 ubiquitin-dependent degradation to enhance alcoholic steatohepatitis","volume":"11","author":"Zhou","year":"2023","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.metabol.2025.156175_bb0130","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2025.156175_bb0135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2017.03.001","article-title":"Deactivating fatty acids: acyl-CoA Thioesterase-mediated control of lipid metabolism","volume":"28","author":"Tillander","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156175_bb0140","first-page":"8","article-title":"ACOT1 deficiency attenuates high-fat diet-induced fat mass gain by increasing energy expenditure","author":"Heden","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2025.156175_bb0145","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1194\/jlr.M046961","article-title":"Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver","volume":"55","author":"Moffat","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156175_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s11658-024-00557-x","article-title":"The micro-743a-3p-GSTM1 pathway is an endogenous protective mechanism against alcohol-related liver disease in mice","volume":"29","author":"Xu","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.metabol.2025.156175_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280270","article-title":"Identification of ARMH4 and WIPF3 as human podocyte proteins with potential roles in immunomodulation and cytoskeletal dynamics","volume":"18","author":"De Luca","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2025.156175_bb0160","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.1922370117","article-title":"Arrestin domain-containing 3 (Arrdc3) modulates insulin action and glucose metabolism in liver","volume":"117","author":"Batista","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2025.156175_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tem.2012.03.003","article-title":"An expanded family of arrestins regulate metabolism","volume":"23","author":"Patwari","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156175_bb0170","article-title":"Prevalence, characteristics and outcomes of patients with metabolic and alcohol related\/associated liver disease (MetALD): a systematic review and meta-analysis","volume":"163","author":"Tampaki","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156175_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/HEP.0000000000000675","article-title":"Alcohol-induced epigenetic changes prevent fibrosis resolution after alcohol cessation in miceresolution","volume":"80","author":"Schonfeld","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2025.156175_bb0180","doi-asserted-by":"crossref","first-page":"ar93","DOI":"10.1091\/mbc.E23-02-0055","article-title":"Divergent regulation of \u03b1-arrestin ARRDC3 function by ubiquitination","volume":"34","author":"Wedegaertner","year":"2023","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.metabol.2025.156175_bb0185","doi-asserted-by":"crossref","first-page":"14510","DOI":"10.1074\/jbc.M116.716589","article-title":"The \u03b1-Arrestin ARRDC3 regulates the endosomal residence time and intracellular signaling of the \u03b22-adrenergic receptor","volume":"291","author":"Tian","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156175_bb0190","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1053\/j.gastro.2016.02.043","article-title":"Alcoholic liver disease in Asia, Europe, and North America","volume":"150","author":"Liangpunsakul","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2025.156175_bb0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.7150\/ijms.34245","article-title":"Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease","volume":"16","author":"Ogawa","year":"2019","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.metabol.2025.156175_bb0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/08923973.2022.2128369","article-title":"ARRDC3 inhibits liver fibrosis and epithelial-to-mesenchymal transition via the ITGB4\/PI3K\/Akt signaling pathway","volume":"45","author":"Zhang","year":"2023","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.metabol.2025.156175_bb0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.metabol.2019.03.010","article-title":"Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis","volume":"95","author":"Lee","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156175_bb0210","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1074\/jbc.M113.527473","article-title":"Structural and biochemical basis for ubiquitin ligase recruitment by arrestin-related domain-containing protein-3 (ARRDC3)","volume":"289","author":"Qi","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156175_bb0215","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1091\/mbc.E15-05-0284","article-title":"The \u03b1-arrestin ARRDC3 mediates ALIX ubiquitination and G protein-coupled receptor lysosomal sorting","volume":"26","author":"Dores","year":"2015","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.metabol.2025.156175_bb0220","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/embor.2010.80","article-title":"Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor","volume":"11","author":"Nabhan","year":"2010","journal-title":"EMBO Rep"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:36:44Z","timestamp":1743986204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S0026049525000447"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156175","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arrestin domain containing 3 promotes alcohol-induced liver steatosis by reducing stearoyl-CoA desaturase-1 ubiquitinated degradation","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156175"}}